Description
Dengvaxia Tetravalent Vaccine: Uses, Side Effects, and Precautions
Dengvaxia Tetravalent Vaccine helps prevent dengue fever caused by all four dengue virus serotypes (DENV-1, DENV-2, DENV-3, and DENV-4). It is recommended for individuals with a prior dengue infection to reduce the risk of severe complications.
Dosage and Administration
- Given as a series of three subcutaneous injections over 12 months.
- Recommended for individuals aged 9-45 years with confirmed past dengue infection.
- Not advised for those without prior dengue exposure due to the risk of severe illness.
Common Side Effects
- Fever
- Headache
- Muscle pain
- Fatigue
- Mild injection site reactions (redness, swelling, or pain)
Serious Side Effects
- Increased risk of severe dengue in individuals without prior infection
- Allergic reactions (swelling, rash, difficulty breathing)
- Severe flu-like symptoms
Seek immediate medical attention if severe side effects occur.
Precautions and Warnings
- Only for individuals with confirmed past dengue infection.
- Not suitable for immunocompromised individuals or those with severe allergies.
- Consult a doctor before use if pregnant or breastfeeding.
- Does not provide complete immunity; continue preventive measures against mosquito bites.
Disclaimer
Products information mentioned on this site is for informative purposes only. The product image belongs to the respective company. Genetec Lifesciences is a wholesaler and distributor, not a manufacturer. We source our medicines directly from the company or authorized vendors of the company.